Physician profile
David E Feece
NPI 1245600956
$5,200.62
in general payments reported to CMS, 2019-2025
38 companies · $953 in 2025
The $953 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $946 · 2022: $1,282 · 2023: $1,201 · 2024: $818 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,878 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,878.44 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $831.70 | 2021-2025 | Erleada |
| Sumitomo Pharma America, INC. | $413.24 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $410.71 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $408.97 | 2021-2023 | Myrbetriq |
| Abbvie INC. | $402.64 | 2022-2025 | |
| Coloplast Corp | $384.72 | 2021-2025 | Speedicath |
| Endo Pharmaceuticals INC. | $352.53 | 2021-2024 | Xiaflex, Aveed |
| Endo USA, INC. | $244.96 | 2024-2025 | Xiaflex, Aveed |
| Boston Scientific Corporation | $221.50 | 2021-2024 | Spaceoar Vue System - 10ml, Rezum Generator, Greenlight Xps |
| Rochester Medical Corporation | $199.96 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $149.53 | 2023-2025 | Magic3 Go Intermittent Urinary Catheter, Bard Urinary Drainage Bag |
| Medtronic, INC. | $130.81 | 2021-2025 | Interstim |
| Urovant Sciences INC | $124.50 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $82.04 | 2024-2025 | Adstiladrin |
| Teleflex LLC | $77.39 | 2021-2023 | Urolift |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $62.32 | 2023-2024 | Axonics, Bulkamid |
| Merck Sharp & Dohme LLC | $60.23 | 2021-2022 | |
| 180 Medical, INC. | $58.44 | 2023-2024 | Gentlecath Glide |
| Laborie Medical Technologies Corp. | $53.10 | 2023-2025 | |
| Hollister Incorporated | $45.34 | 2023-2024 | Infyna Chic, Vapro, Vapro Pocket |
| Pfizer INC. | $41.99 | 2022-2025 | |
| Olympus America INC. | $40.33 | 2025 | Itind System |
| Procept Biorobotics Corporation | $37.89 | 2025 | |
| Blue Earth Diagnostics | $37.64 | 2021-2023 | |
| Urogen Pharma, INC. | $36.68 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $29.02 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $27.40 | 2025 | Rexulti |
| Halozyme INC | $27.32 | 2023 | |
| Clarus Therapeutics INC. | $27.23 | 2021 | |
| Sagent Pharmaceuticals | $26.12 | 2024 | Glydo |
| Tolmar, INC. | $24.45 | 2024 | |
| Becton, Dickinson and Company | $24.25 | 2024 | |
| Myovant Sciences INC. | $21.87 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.42 | 2025 | Trintellix |
| Davol INC. | $17.13 | 2025 | |
| Abc Home Medical Supply, INC. | $16.24 | 2024 | |
| Phathom Pharmaceuticals, INC. | $15.64 | 2025 | Voquezna |
| Ambu INC. | $15.37 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Feece listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.